GSK under pressure to acquire other firms to build pipeline

GlaxoSmithKline is under strong pressure from institutional investors to use its billions in cash reserves rather than saving them. Investors are clamoring for GSK to acquire other companies as part of a broader effort to improve its drug pipeline.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY